PL356897A1 - High stability bacteriophage preparation and application of block copolymer of ethyl oxide and propylene oxide - Google Patents

High stability bacteriophage preparation and application of block copolymer of ethyl oxide and propylene oxide

Info

Publication number
PL356897A1
PL356897A1 PL02356897A PL35689702A PL356897A1 PL 356897 A1 PL356897 A1 PL 356897A1 PL 02356897 A PL02356897 A PL 02356897A PL 35689702 A PL35689702 A PL 35689702A PL 356897 A1 PL356897 A1 PL 356897A1
Authority
PL
Poland
Prior art keywords
oxide
application
block copolymer
high stability
propylene oxide
Prior art date
Application number
PL02356897A
Other languages
Polish (pl)
Other versions
PL199642B1 (en
Inventor
Janusz Boratyński
Andrzej Górski
Tomasz Lipiński
Danuta Syper
Beata Weber-Dąbrowska
Original Assignee
Instytut Immunologii i Terapii Doświadczalnej PAN
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Instytut Immunologii i Terapii Doświadczalnej PAN filed Critical Instytut Immunologii i Terapii Doświadczalnej PAN
Priority to PL356897A priority Critical patent/PL199642B1/en
Priority to AU2003286984A priority patent/AU2003286984A1/en
Priority to PCT/PL2003/000123 priority patent/WO2004045645A2/en
Publication of PL356897A1 publication Critical patent/PL356897A1/en
Publication of PL199642B1 publication Critical patent/PL199642B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/12011—Details dsRNA Bacteriophages
    • C12N2795/12032—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Zaprezentowano preparaty bakteriofagowe o podwyższonej stabilności oraz nowe zastosowanie blokowych kopolimerów tlenku etylenu i tlenku propylenu do stabilizowania aktywności preparatów bakteriofagowych. Stabilizowane preparaty bakteriofagowe o podwyższonej trwałości znajdują zastosowanie w lecznictwie.Bacteriophage preparations with increased stability and a new application of block copolymers of ethylene oxide and propylene oxide to stabilize the activity of bacteriophage preparations were presented. Stabilized bacteriophage preparations with increased durability are used in medicine.

PL356897A 2002-11-15 2002-11-15 High stability bacteriophage preparation and application of block copolymer of ethyl oxide and propylene oxide PL199642B1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
PL356897A PL199642B1 (en) 2002-11-15 2002-11-15 High stability bacteriophage preparation and application of block copolymer of ethyl oxide and propylene oxide
AU2003286984A AU2003286984A1 (en) 2002-11-15 2003-11-15 A bacteriophage preparation of enhanced stability by application of a block copolymer of ethylene oxide and propylene oxide
PCT/PL2003/000123 WO2004045645A2 (en) 2002-11-15 2003-11-15 A bacteriophage preparation of enhanced stability by application of a block copolymer of ethylene oxide and propylene oxide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL356897A PL199642B1 (en) 2002-11-15 2002-11-15 High stability bacteriophage preparation and application of block copolymer of ethyl oxide and propylene oxide

Publications (2)

Publication Number Publication Date
PL356897A1 true PL356897A1 (en) 2004-05-17
PL199642B1 PL199642B1 (en) 2008-10-31

Family

ID=32322590

Family Applications (1)

Application Number Title Priority Date Filing Date
PL356897A PL199642B1 (en) 2002-11-15 2002-11-15 High stability bacteriophage preparation and application of block copolymer of ethyl oxide and propylene oxide

Country Status (3)

Country Link
AU (1) AU2003286984A1 (en)
PL (1) PL199642B1 (en)
WO (1) WO2004045645A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1812025T3 (en) * 2004-11-02 2012-10-22 Chr Hansen As STABILIZED BACTERIOPHAGIC FORMULATIONS
TWI573874B (en) * 2008-12-05 2017-03-11 武田疫苗股份有限公司 Compositions, methods and uses for inducing viral growth
WO2013180316A1 (en) * 2012-05-29 2013-12-05 주식회사 인트론바이오테크놀로지 Composition capable of improving stability of bacteriophage lysine proteins
EP4261274A1 (en) * 2022-04-13 2023-10-18 Merck Patent GmbH Meroxapols for cell culture

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB771653A (en) * 1955-08-31 1957-04-03 Medico Biolog Lab Ltd Stabilized bacteriophages
US5616487A (en) * 1994-09-15 1997-04-01 Aastrom Biosciences, Inc. Stabilized retrovirus compositions
US6322783B1 (en) * 1996-08-26 2001-11-27 Seishi Takahashi Bacteriophages, method for screening same and bactericidal compositions using same, and detection kits using same
MXPA01010124A (en) * 1999-04-09 2002-06-26 Aventis Pharma Sa Composition for the preservation of infectious recombinant adenoviruses.
AU4346101A (en) * 2000-03-07 2001-09-17 Merck & Co., Inc. Adenovirus formulations

Also Published As

Publication number Publication date
AU2003286984A1 (en) 2004-06-15
AU2003286984A8 (en) 2004-06-15
PL199642B1 (en) 2008-10-31
WO2004045645A3 (en) 2004-07-29
WO2004045645A2 (en) 2004-06-03

Similar Documents

Publication Publication Date Title
EA200200812A1 (en) PHARMACEUTICAL COMPOSITION CONTAINING LOW DOSE OF ENTEKAVIR, AND ITS APPLICATION
AR012614A1 (en) A PHARMACEUTICAL COMPOSITION FOR THE MANUFACTURE OF A MEDICINAL PRODUCT INTENDED FOR THE TREATMENT OF A SUSCEPTIBLE VIRAL INFECTION OF TREATMENT WITH ALPHA INTERFER, A METHOD FOR THE MANUFACTURE OF A MEDICINAL PRODUCT, FOR THE MANUFACTURE OF A MEDICINE
PA8539901A1 (en) NOVEDOUS O-DESMETIL-VENLAFAXINE SUCCINATE SALT
NO20022998D0 (en) Pharmaceutical preparations which provide increased concentration of drug
SE9701162D0 (en) New use II
DE602004019887D1 (en) PHYSIOLOGICALLY EFFECTIVE POLYPEPTIDE CONJUGATE WITH EXTENDED IN VIVO HALF TIME
EA200101156A1 (en) DRUG COMPOSITIONS OF A NEW TYPE ON THE BASIS OF POSSESSING HOLYNTHERGIC ACTION OF COMPOUNDS AND β-MIMETIC
EE05383B1 (en) Pol arecarboxamide Compounds, Preparation and Use of Aliphatic Lowering Active Ingredients and Pharmaceutical Ingredients
MY125516A (en) Novel composition based on thiazolidinedione and metformin and use
SG146442A1 (en) Sulphonamide derivatives, their preparation and use as medicaments
SE9900961D0 (en) Novel compounds
CY1110061T1 (en) COMPOSITIONS INCLUDING MODAFINILIS COMPOUNDS
SE9802208D0 (en) Novel compounds
AR025330A1 (en) COMBINATION OF ACTIVE SUBSTANCES WITH CLONIDINE
BR0209645A (en) Oxazole and furopyrimidines and their use as medicines
SE9701161D0 (en) New use I
ATE478662T1 (en) MEDICINAL SOLUTIONS CONTAINING MODAFINIL COMPOUNDS
TR200401363T4 (en) Treatment of DNA viral infections
AU2002332488A1 (en) R-bambuterol, its preparation and therapeutic uses
PL356897A1 (en) High stability bacteriophage preparation and application of block copolymer of ethyl oxide and propylene oxide
SE9802209D0 (en) Novel compounds
PL368686A1 (en) Novel aminobenzoephenones
DE60309480D1 (en) VITAMIN D ANALOG
DE60125232D1 (en) SMALL ACID SOLUBLE PROTEIN AND ITS USES
MY130445A (en) Novel formulations of alpha-2, 4-disulfophenyl-n-tert-butylnitrone